000865828 001__ 865828
000865828 005__ 20210130003150.0
000865828 0247_ $$2doi$$a10.1002/hbm.24838
000865828 0247_ $$2ISSN$$a1065-9471
000865828 0247_ $$2ISSN$$a1097-0193
000865828 0247_ $$2Handle$$a2128/23996
000865828 0247_ $$2altmetric$$aaltmetric:69068293
000865828 0247_ $$2pmid$$apmid:31633254
000865828 0247_ $$2WOS$$aWOS:000491156400001
000865828 037__ $$aFZJ-2019-05119
000865828 082__ $$a610
000865828 1001_ $$0P:(DE-HGF)0$$aAdhikari, Bhim M.$$b0
000865828 245__ $$aEffects of Ketamine and Midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia
000865828 260__ $$aNew York, NY$$bWiley-Liss$$c2020
000865828 3367_ $$2DRIVER$$aarticle
000865828 3367_ $$2DataCite$$aOutput Types/Journal article
000865828 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1579705204_19971
000865828 3367_ $$2BibTeX$$aARTICLE
000865828 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000865828 3367_ $$00$$2EndNote$$aJournal Article
000865828 500__ $$aNIH. Grant Numbers: T32MH067533, R01MH085646, R01DA027680, R01MH112180, R01EB015611, U01MH108148, U54EB020403
000865828 520__ $$aSubanesthetic administration of ketamine is a pharmacological model to elicit positiveand negative symptoms of psychosis in healthy volunteers. We used resting statepharmacological functional MRI (rsPhfMRI) to identify cerebral networks affected by ketamineand compared them to the functional connectivity (FC) in schizophrenia. Ketamine can producesedation and we contrasted its effects with the effects of the anxiolytic drug midazolam.Thirty healthy male volunteers (age=19-37 years) underwent a randomized, three-way,cross-over study consisting of three imaging sessions, with 48 hours between sessions. A sessionconsisted of a control period followed by infusion of placebo or ketamine or midazolam. TheENIGMA rsfMRI pipeline was used to derive two long distance (seed-based and dualregression)and one local (regional homogeneity, ReHo) FC measures. Ketamine inducedsignificant reductions in the connectivity of the salience network (Cohen’s d:1.13±0.28,p=4.0×10-3), auditory network (d: 0.67±0.26, p=0.04) and default mode network (DMN,d:0.63±0.26, p=0.05). Midazolam significantly reduced connectivity in the DMN (d:0.77±0.27,p=0.03). The effect sizes for ketamine for resting networks showed a positive correlation(r=0.59, p=0.07) with the effect sizes for schizophrenia related deficits derived from ENIGMA’sstudy of 261 patients and 327 controls. Effect sizes for midazolam were not correlated with theschizophrenia pattern (r=-0.17, p=0.65). The subtraction of ketamine and midazolam patternsshowed a significant positive correlation with the pattern of schizophrenia deficits (r=0.68,p=0.03).RsPhfMRI reliably detected the shared and divergent pharmacological actions ofketamine and midazolam on cerebral networks. The pattern of disconnectivity produced byketamine was positively correlated with the pattern of connectivity deficits observed inschizophrenia, suggesting a brain functional basis for previously poorly understood effects of thedrug.
000865828 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000865828 536__ $$0G:(DE-HGF)POF3-571$$a571 - Connectivity and Activity (POF3-571)$$cPOF3-571$$fPOF III$$x1
000865828 588__ $$aDataset connected to CrossRef
000865828 7001_ $$0P:(DE-Juel1)177772$$aDukart, Juergen$$b1
000865828 7001_ $$0P:(DE-HGF)0$$aHipp, Joerg F.$$b2
000865828 7001_ $$0P:(DE-HGF)0$$aForsyth, Anna$$b3
000865828 7001_ $$0P:(DE-HGF)0$$aMcMillan, Rebecca$$b4
000865828 7001_ $$0P:(DE-HGF)0$$aMuthukumaraswamy, Suresh D.$$b5
000865828 7001_ $$0P:(DE-HGF)0$$aRyan, Meghann C.$$b6
000865828 7001_ $$0P:(DE-HGF)0$$aElliot Hong, L.$$b7
000865828 7001_ $$0P:(DE-Juel1)131678$$aEickhoff, Simon$$b8$$ufzj
000865828 7001_ $$0P:(DE-HGF)0$$aJahanshad, Neda$$b9
000865828 7001_ $$0P:(DE-HGF)0$$aThompson, Paul M.$$b10
000865828 7001_ $$0P:(DE-HGF)0$$aRowland, Laura M.$$b11
000865828 7001_ $$0P:(DE-HGF)0$$aKochunov, Peter$$b12$$eCorresponding author
000865828 773__ $$0PERI:(DE-600)1492703-2$$a10.1002/hbm.24838$$gp. hbm.24838$$n3$$p767-778$$tHuman brain mapping$$v41$$x1065-9471$$y2020
000865828 8564_ $$uhttps://juser.fz-juelich.de/record/865828/files/Adhikari_et_al-2020-Human_Brain_Mapping.pdf$$yOpenAccess
000865828 8564_ $$uhttps://juser.fz-juelich.de/record/865828/files/Adhikari_et_al-2020-Human_Brain_Mapping.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000865828 909CO $$ooai:juser.fz-juelich.de:865828$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000865828 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131678$$aForschungszentrum Jülich$$b8$$kFZJ
000865828 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000865828 9131_ $$0G:(DE-HGF)POF3-571$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vConnectivity and Activity$$x1
000865828 9141_ $$y2020
000865828 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000865828 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000865828 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000865828 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHUM BRAIN MAPP : 2017
000865828 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000865828 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000865828 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000865828 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000865828 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000865828 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000865828 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000865828 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000865828 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000865828 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000865828 920__ $$lyes
000865828 9201_ $$0I:(DE-Juel1)INM-7-20090406$$kINM-7$$lGehirn & Verhalten$$x0
000865828 980__ $$ajournal
000865828 980__ $$aVDB
000865828 980__ $$aUNRESTRICTED
000865828 980__ $$aI:(DE-Juel1)INM-7-20090406
000865828 9801_ $$aFullTexts